Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications consumed more than 80% of Medicare Part D spending, researchers reported.
A machine learning project focused on predicting chronic kidney disease (CKD) stages and performing survival analysis using clinical biomarkers. It utilizes the Kaplan-Meier estimator to analyze ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
You can also manage mailboxes from the Mailboxes page in the Email Security console.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback